MENU
PALI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Palisade Bio (PALI) Earnings Date & Reports
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier... Show more
A.I. Advisor
published Earnings
PALI is expected to report earnings to -5 cents per share on August 25
Q2'26
Est.
$-0.05
Q1'26
Beat
by $0.39
Q4'25
Beat
by $0.23
Q3'25
Beat
by $0.17
Q2'25
Beat
by $0.21
The last earnings report on May 12 showed earnings per share of -5 cents, beating the estimate of -43 cents. With 3.95M shares outstanding, the current market capitalization sits at 304.11M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds
Industry Biotechnology
Profile
Details
Industry
N/A
Address
4600 South Syracuse Street
Phone
+1 858 704-4900
Employees
14
Web
https://www.palisadebio.com